Prior studies demonstrated that low serum ALB is an independent predictor of poor survival in several types of cancer including gastrointestinal cancer, lung cancer, ovarian cancer and breast cancer, as well as NPC [11], [12]. This evidence concerns the gene ALB and cancer.